Michael Gent

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Agnes Lee, Mark N. Levine, Ross Baker et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

Theodore E. Warkentin, Mark N. Levine, Jack Hirsh et al. · New England Journal of Medicine · 1995 · 2.3K citations · Full text

Canadian Implantable Defibrillator Study (CIDS)

Stuart J. Connolly, Michael Gent, Robin S. Roberts et al. · Circulation · 2000 · 1.6K citations

Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction

Stefan H. Hohnloser, Karl Heinz Kuck, Paul Dorian et al. · New England Journal of Medicine · 2004 · 1.5K citations